Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

HIV Infection

Free Subscription 11.10.2021 5 AIDS 3 Antivir Ther 5 Clin Infect Dis 2 HIV Med 1 J Acquir Immune Defic Syndr 1 J Clin Invest 3 J Infect Dis 4 J Med Virol 2 J Virol 2 Lancet Infect Dis 1 MMWR Morb Mortal Wkly Rep 4 N Engl J Med 2 Nat Med 3 Pediatr Infect Dis J 5 PLoS One 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. FORD N, Crawford KW, Ameyan W
   Rapidly starting antiretroviral therapy to improve outcomes among disadvantaged groups.
   AIDS. 2021;35:2217-2219.
   PubMed        
   
   
2. BEZEMER D, Blenkinsop A, Hall M, van Sighem A, et al
   In-country acquisition of HIV-1 non-B infection within the Netherlands is frequent, but results in limited onward transmission.
   AIDS. 2021 Oct 5. pii: 00002030-900000000-96312.
   PubMed         Abstract available
   
   
3. SHAIKH K, Bhondoekhan F, Haberlen S, Nakanishi R, et al
   Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection.
   AIDS. 2021 Oct 4. pii: 00002030-900000000-96300.
   PubMed         Abstract available
   
   
4. YIN W, Panakadan S, Shwe YY, Peters K, et al
   Enhance harm reduction programmes in responding to the changing trend of drug use and HIV transmission in Asia and the pacific.
   AIDS. 2021;35:2229-2232.
   PubMed        
   
   
5. MOSES AK, Ghazi T, Naidoo DB, Chuturgoon A, et al
   DNA methylation of MEKKK1: a strategy to reactivate the NF-kappaB pathway and reverse HIV latency.
   AIDS. 2021;35:2221-2224.
   PubMed        
   
   

   
   Antivir Ther

6. BLACKMAN AL, Heil EL, Devanathan AS, Pandit NS, et al
   The effect of veno-arterial extracorporeal oxygenation and nasogastric tube administration on the pharmacokinetic profile of abacavir, lamivudine and dolutegravir: a case report.
   Antivir Ther. 2020 Apr 28. doi: 10.3851/IMP3355.
   PubMed         Abstract available
   
   
7. HOFFMANN C, Schewe K, Fenske S, Buhk T, et al
   Short-term neuropsychiatric tolerability of bictegravir combined with emtricitabine/tenofovir alafenamide in clinical practice.
   Antivir Ther. 2020 Apr 1. doi: 10.3851/IMP3351.
   PubMed         Abstract available
   
   
8. ZHANG Q, Li X, Qiao S, Shen Z, et al
   Factors influencing hair lamivudine concentration among people living with HIV in Guangxi, China.
   Antivir Ther. 2020 Jun 1. doi: 10.3851/IMP3360.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

9. IMPERIAL MZ, Nedelman JR, Conradie F, Savic RM, et al
   Proposed linezolid dosing strategies to minimize adverse events for treatment of extensively drug-resistant tuberculosis.
   Clin Infect Dis. 2021 Oct 4. pii: 6380680. doi: 10.1093.
   PubMed         Abstract available
   
   
10. SACCENTE M, Krishnan G
    Comparison of Blood (1->3)-beta-d-Glucan Levels in AIDS-Related Pneumocystis jirovecii Pneumonia and AIDS-Related Progressive Disseminated Histoplasmosis.
    Clin Infect Dis. 2021;73:1100-1102.
    PubMed         Abstract available
    
    
11. FACENTE SN, Patel S, Hecht J, Wilson E, et al
    Hepatitis C care cascades for three populations at high risk: low-income trans women, young people who inject drugs, and men who have sex with men and inject drugs.
    Clin Infect Dis. 2021 Mar 26. pii: 6188771. doi: 10.1093.
    PubMed         Abstract available
    
    
12. MCGINNIS KA, Justice AC, Moore RD, Silverberg MJ, et al
    Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America.
    Clin Infect Dis. 2021 Oct 5. pii: 6381559. doi: 10.1093.
    PubMed         Abstract available
    
    
13. GIANELLA S, Rawlings SA, Nakazawa M, Chaillon A, et al
    Sex differences in HIV Persistence and Reservoir Size during Aging.
    Clin Infect Dis. 2021 Oct 6. pii: 6382188. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

14. TUFA TB, Fuchs A, Orth HM, Lubke N, et al
    Characterization of HIV-1 drug resistance among patients with failure of second-line combined antiretroviral therapy in central Ethiopia.
    HIV Med. 2021 Oct 7. doi: 10.1111/hiv.13176.
    PubMed         Abstract available
    
    
15. HOVAGUIMIAN F, Martin E, Reinacher M, Rasi M, et al
    Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.
    HIV Med. 2021 Oct 3. doi: 10.1111/hiv.13175.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

16. TRUJILLO L, Robbins T, Morris E, Sionean C, et al
    Material hardship and association with sexual risk behavior among adolescent sexual minority males in 3 U.S. cities - National HIV Behavioral Surveillance-Young Men who Have Sex with Men, 2015.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95789.
    PubMed         Abstract available
    
    

    
    J Clin Invest

17. DIAS J, Fabozzi G, March K, Asokan M, et al
    Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging.
    J Clin Invest. 2021;131.
    PubMed         Abstract available
    
    

    
    J Infect Dis

18. TINGGAARD M, Slotved HC, Fuursted K, Storgaard M, et al
    Oral and anal carriage of Streptococcus pneumoniae among sexually active men with HIV who have sex with men.
    J Infect Dis. 2021 Oct 8. pii: 6383604. doi: 10.1093.
    PubMed         Abstract available
    
    
19. LECUYER R, Issa N, Tessoulin B, Lavergne RA, et al
    Epidemiology and clinical impact of respiratory co-infections at diagnosis of Pneumocystis jirovecii Pneumonia.
    J Infect Dis. 2021 Oct 4. pii: 6380657. doi: 10.1093.
    PubMed         Abstract available
    
    
20. AKATA K, Leung JM, Yamasaki K, Filho FSL, et al
    Altered polarization and impaired phagocytic activity of lung macrophages in people with HIV and COPD.
    J Infect Dis. 2021 Oct 5. pii: 6381638. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

21. DAI L, Jung BG, Chen J, Samten B, et al
    The potential impacts of early secreted antigenic target of 6 kDa of Mycobacterium tuberculosis on KSHV-infected cells.
    J Med Virol. 2021;93:4028-4032.
    PubMed         Abstract available
    
    
22. DA SILVA PRATES G, Malta FM, de Toledo Goncalves F, Monteiro MA, et al
    AIDS incidence and survival in a hospital-based cohort of HIV-positive patients from Sao Paulo, Brazil: The role of IFN-lambda4 polymorphisms.
    J Med Virol. 2021;93:3601-3606.
    PubMed         Abstract available
    
    
23. SILVA DMD, Goncales JP, Silva Junior JVJ, Lopes TRR, et al
    Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-alpha, and IFN-gamma cytokines in HIV/HHV-8 coinfection.
    J Med Virol. 2021;93:4033-4037.
    PubMed         Abstract available
    
    
24. LU J, Jia J, Zhang J, Liu X, et al
    HIV p17 enhances T cell proliferation by suppressing autophagy through the p17-OLA1-GSK3beta axis under nutrient starvation.
    J Med Virol. 2021;93:3607-3620.
    PubMed         Abstract available
    
    

    
    J Virol

25. SOWD GA, Shi J, Aiken C
    HIV-1 CA inhibitors are antagonized by inositol phosphate stabilization of the viral capsid in cells.
    J Virol. 2021 Oct 6:JVI0144521. doi: 10.1128/JVI.01445.
    PubMed         Abstract available
    
    
26. KURNAEVA MA, Zalevsky AO, Arifulin EA, Lisitsyna OM, et al
    Molecular coevolution of nuclear and nucleolar localization signals inside basic domain of HIV-1 Tat.
    J Virol. 2021 Oct 6:JVI0150521. doi: 10.1128/JVI.01505.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

27. KRUTIKOV M, Faust L, Nikolayevskyy V, Hamada Y, et al
    The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-gamma release assays: a systematic review and meta-analysis.
    Lancet Infect Dis. 2021 Oct 1. pii: S1473-3099(21)00261.
    PubMed         Abstract available
    
    
28. RULE R, Mitton B, Govender NP, Hoffmann D, et al
    Spinal epidural abscess caused by Aspergillus spp masquerading as spinal tuberculosis in a person with HIV.
    Lancet Infect Dis. 2021 Sep 29. pii: S1473-3099(20)30979.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

29. RAO S, Mulatu MS, Xia M, Wang G, et al
    HIV Preexposure Prophylaxis Awareness and Referral to Providers Among Hispanic/Latino Persons - United States, 2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:1395-1400.
    PubMed         Abstract available
    
    

    
    N Engl J Med

30. CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
    Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
    PubMed         Abstract available
    
    
31. KLEIN MD, Keen SK, Simpson RJ Jr
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed        
    
    
32. OLALLA J, Pombo M
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed        
    
    
33. TSENG ZH, Hsue PY, Moffatt E
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV. Reply.
    N Engl J Med. 2021;385:e50.
    PubMed        
    
    

    
    Nat Med

34. STEPHENSON KE, Julg B, Tan CS, Zash R, et al
    Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
    Nat Med. 2021 Oct 7. pii: 10.1038/s41591-021-01509.
    PubMed         Abstract available
    
    
35. MATTHEWS RP, Patel M, Barrett SE, Haspeslagh L, et al
    Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial.
    Nat Med. 2021 Oct 4. pii: 10.1038/s41591-021-01479.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

36. HRAPCAK S, Bekele A, Ahmed J, Ayalew J, et al
    Finding Children Living With HIV in Low-prevalence Countries: HIV Prevalence and Testing Yield From 5 Entry Points in Ethiopia.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95684.
    PubMed         Abstract available
    
    
37. WEYLAND C, Mirani G, Gillespie SL, Paul ME, et al
    A Case of in utero Transmission of Drug-resistant HIV in the United States.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95685.
    PubMed         Abstract available
    
    
38. MILLER C, Daugherty R, McCulloch M, Stephens I, et al
    Immune Reconstitution Inflammatory Syndrome Complicating Cryptococcal Meningitis in a Pediatric Heart Transplant Patient.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95687.
    PubMed         Abstract available
    
    

    
    PLoS One

39. GIGUERE K, Vaziri M, Olivier C, Charest L, et al
    Characteristics of new HIV diagnoses over 1995-2019: A clinic-based study in Montreal, Canada.
    PLoS One. 2021;16:e0258383.
    PubMed         Abstract available
    
    
40. KUHNS LM, Johnson AK, Adetunji A, Kuti KM, et al
    Adaptation of evidence-based approaches to promote HIV testing and treatment engagement among high-risk Nigerian youth.
    PLoS One. 2021;16:e0258190.
    PubMed         Abstract available
    
    
41. GE E, Li Y, Wu S, Candido E, et al
    Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    PLoS One. 2021;16:e0258154.
    PubMed         Abstract available
    
    
42. SAINE ME, Szymczak JE, Moore TM, Bamford LP, et al
    The impact of disease-related knowledge on perceptions of stigma among patients with Hepatitis C Virus (HCV) infection.
    PLoS One. 2021;16:e0258143.
    PubMed         Abstract available
    
    
43. GOUNTAS I, Nikolopoulos G, Touloumi G, Fotiou A, et al
    Could the 2010 HIV outbreak in Athens, Greece have been prevented? A mathematical modeling study.
    PLoS One. 2021;16:e0258267.
    PubMed         Abstract available
    
    

    
    Vaccine

44. KHAIMOVA R, Fischetti B, Cope R, Berkowitz L, et al
    Serological response with Heplisav-B(R) in prior Hepatitis B vaccine non-responders living with HIV.
    Vaccine. 2021 Sep 29. pii: S0264-410X(21)01251.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: